EXHIBIT 10.36 EMPLOYMENT AGREEMENT This Employment Agreement ("Agreement") is entered into as of the 15th day of December, 1995, (the "Effective Date") by and between Mary Ellen Pollin ("Employee") and Home Shopping Network, Inc. ("the Company")....Employment Agreement • March 28th, 1996 • Home Shopping Network Inc • Retail-catalog & mail-order houses • Florida
1 EXHIBIT 10.37 FOURTH AMENDMENT, dated as of February 13, 1996, to the SECOND AMENDED AND RESTATED CREDIT AGREEMENT, dated as of August 30, 1994 (as amended by the First Amendment thereto, dated as of March 29, 1995, as further amended by the Second...Credit Agreement • March 28th, 1996 • Home Shopping Network Inc • Retail-catalog & mail-order houses • New York
Exhibit 10.21 CONSULTING SERVICES AGREEMENT THIS CONSULTING SERVICES AGREEMENT entered into this 10th day of January, 2005 (hereinafter "Effective Date") by and between STONE STREET ADVISORS, LLC, a Nevada Limited Liability Company ("Stone Street")...Consulting Services Agreement • February 25th, 2005 • McKenzie Bay International LTD • Electric services • New Jersey
AMENDMENT to 8% SECURED CONVERTIBLE NOTE DUE NOVEMBER 30, 20098% Secured Convertible Note • May 1st, 2018 • Intellinetics, Inc. • Services-prepackaged software
This Amendment (“Amendment”) to the 8% Secured Convertible Notes due November 30, 2009, dated November 17, 2017 and November 29, 2017 (the “Notes”) is entered into and effective as of the last date indicated below, by and between Intellinetics, Inc., a Nevada corporation (the “Company”) and the holders of the Notes (the “Holders”).
AMENDMENT NO. 3 TO THE AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • May 1st, 2023 • Dare Bioscience, Inc. • Pharmaceutical preparations
This Amendment No. 3 to the Amended and Restated Exclusive License Agreement is entered into by and among Fred Mermelstein, Ph.D. and Janet Chollet, M.D. (the “Licensors”), Pear Tree Pharmaceuticals, Inc., a corporation duly organized and existing under the laws of the State of Delaware (the “Licensee”) and Bernadette Klamerus (“Klamerus”), effective as of February 13, 2017 (“Amendment No. 3 Effective Date”).
